Pranaychandra Vaidya
Interventional Cardiology · Hackensack, NJNPI 1659322204
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $30,869 of the $49,811 with a category attached, or 62.0%. Amgen accounts for 65.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $16,945 and has fallen 64.5% since, to $6,015 in 2025.
Across 252 payments — averaging $197.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$33K
- Medtronic$8K
- Abiomed$6K
- Abbott$640
- Boston Scientific$583
- Edwards Lifesciences$471
- plus $2K from 15 others
Across 28 payments — averaging $229.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$6K
- Abiomed$119
What the payments were for
- Speaking & faculty fees$30,86962%
- Travel & lodging$6,89214%
- Food & beverage$11,91424%
- Education$1360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 31 | $32,691 |
| Medtronic | 60 | $7,565 |
| Abiomed | 101 | $5,796 |
| Abbott | 5 | $640 |
| Boston Scientific | 8 | $583 |
| Edwards Lifesciences | 4 | $471 |
| Siemens Medical Solutions USA, Inc. | 4 | $423 |
| Spectrawave, Inc | 2 | $376 |
| Shockwave Medical, Inc | 2 | $178 |
| Saranas, Inc. | 1 | $154 |
| Silk Road Medical, Inc. | 1 | $141 |
| Amarin Pharma, Inc. | 23 | $136 |
| Cardiovascular Systems Inc. | 1 | $130 |
| Teleflex LLC | 2 | $127 |
| AstraZeneca | 1 | $116 |
| Ancora Heart, Inc. | 1 | $103 |
| Penumbra, Inc. | 1 | $102 |
| Lantheus Medical Imaging, Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| Irhythm Technologies, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$32,479
- RESOLUTE ONYX$4,025
- Impella$2,925
- ONYX FRONTIER$1,563
- SYMPLICITY G3$563
- HyperVue Imaging System$376
- Starlight Imaging Catheter$376
- ARTIS icono biplane$229
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$167
- Artis icono floor$157
- Optis Coronary Imaging System$142
- ENROUTE Transcarotid Neuroprotection System$141
- ENROUTE Transcarotid Stent System$141
- ENHANCE Transcarotid Peripheral Access Kit$141
- ENROUTE 0.014 Guidewire$141
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$134
- Proclaim IPG$131
- Diamondback Coronary$130
- AVVIGO Guidance System$127
- SAPIEN 3 Ultra RESILIA$119
How this compares
$49,811 in reported general payments places this provider in the 85th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $94,815 |
| EntrestoSacubitril/Valsartan | 23 | $27,540 |
| Repatha SureclickEvolocumab | 11 | $8,910 |
| VytorinEzetimibe/Simvastatin | 11 | $4,230 |
| Ranolazine ErRanolazine | 27 | $3,286 |
| Metoprolol Succinate | 153 | $3,013 |
| Atorvastatin Calcium | 137 | $1,459 |
| ClopidogrelClopidogrel Bisulfate | 100 | $1,292 |
| Rosuvastatin Calcium | 72 | $849 |
| Amlodipine Besylate | 84 | $748 |
| Ezetimibe | 41 | $684 |
| Furosemide | 81 | $487 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $452 |
| Losartan Potassium | 26 | $407 |
| Carvedilol | 13 | $277 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Hackensack
- Michael LimHackensack$215K
- Ryan KapleHackensack$178K
- Sung-Han YoonHackensack$105K
- Hemal BhattHackensack$26K
- Justin LeeHackensack$13K
- Ankitkumar PatelGlen Ridge$408K
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Darshan GodkarCedar Knolls$194K
- Matthew SayboltEatontown$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.